EQT收购生命科学产品分销商Europa Biosite-动脉网

EQT to acquire Europa Biosite, a distributor of life science products

CISION 等信源发布 2025-07-03 15:08



可切换为仅中文







EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across

EQT Healthcare Growth 将收购 Europa Biosite，这是一家向学术界和生物制药研究人员分销超过一千万种高质量生命科学试剂的公司。

Europe

欧洲

and

和

North America

北美

, from Adelis Equity

，来自阿德尔伊斯股权

EQT will support Europa Biosite's next phase of growth through commercial excellence initiatives, digital upgrades, expanded product access, and continued M&A, with the company set to benefit from continued demand for advanced research tools

EQT将通过商业卓越计划、数字化升级、扩大产品覆盖范围以及持续的并购来支持Europa Biosite下一阶段的增长，该公司将继续受益于对先进研究工具的持续需求。

The investment builds on EQT's track record in specialised distribution, including Azelis, Beijer Ref, and OEM International

这项投资建立在EQT在专业分销领域的业绩基础上，包括Azelis、Beijer Ref和OEM International。

STOCKHOLM

斯德哥尔摩

，

July 3, 2025

2025年7月3日

/PRNewswire/ -- EQT Healthcare Growth ('EQT') has agreed to acquire a majority stake in Europa Biosite (or 'the Company') - a distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances used in healthcare R&D - from Adelis Equity. Headquartered in .

/PRNewswire/ -- EQT医疗成长基金（“EQT”）已同意从Adelis Equity手中收购Europa Biosite（或“公司”）的多数股权。该公司是一家高品质研究用（RUO）生命科学试剂、化学品和生物物质的分销商，这些产品用于医疗研发。公司总部位于。

Stockholm

斯德哥尔摩

, the Company operates in 17 countries across

，公司在17个国家开展业务，遍布

Europe

欧洲

and North America and supports more than 60,000 researchers in academia and biopharma.

并在北美支持超过60,000名学术界和生物制药领域的研究人员。

Europa Biosite offers access to over ten million individual scientific products essential to life sciences research, such as antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens, from a wide range of science-led suppliers. It has grown to become a partner for both suppliers and scientists, building on its highly localized footprint and strong technical sales capabilities.

欧洲生物站点提供超过一千万种生命科学研究必需的个别科学产品，如抗体、生化试剂、诊断试剂盒和符合伦理的生物样本，来自各种以科学为主导的供应商。它已经发展成为供应商和科学家的合作伙伴，依托其高度本地化的业务布局和强大的技术销售能力。

The Company serves a fragmented and fast-moving industry, which is expected to benefit from stable research funding..

公司服务于一个分散而快速发展的行业，预计该行业将受益于稳定的研究资金。

EQT Healthcare Growth seeks to scale healthcare companies by building commercial muscle and expanding reach, building on EQT's three-decade track record in the healthcare sector. Europa Biosite will draw on this experience to expand its own-brand offering in biospecimens, continue its acquisition strategy to strengthen local market presence and expand to new geographies, and invest in new digital infrastructure.

EQT Healthcare Growth 旨在通过增强商业实力和扩大覆盖范围，推动医疗公司的规模化发展，依托EQT在医疗领域三十年的卓越业绩。Europa Biosite 将借鉴这一经验，拓展其自有品牌的生物样本产品线，持续推进收购战略以强化本地市场地位并进军新地域，同时投资于新型数字基础设施。

The Company is also set to benefit from EQT's track record in specialized distribution, including Azelis, Beijer Ref, and OEM International, as well as EQT's industrial advisor network, with senior EQT advisor .

公司还将受益于EQT在专业分销领域的成功经验，包括Azelis、Beijer Ref和OEM International，以及EQT的工业顾问网络，拥有资深EQT顾问。

Kate Swann

凯特·斯旺

set to lead Europa Biosite's Board.

将领导欧罗巴生物基地的董事会。

Rikke Kjær Nielsen, Partner in the EQT Healthcare Growth advisory team, commented: 'Europa Biosite supports European scientific research by connecting thousands of labs with the reagents they need to advance discovery. With our support, the company will be set up to scale its business through investments into digital tools, strengthening of its supplier network, and acceleration of its M&A platform.

EQTV生命科学成长顾问团队的合伙人里克·凯尔·尼尔森评论道：“Europa Biosite通过为数千个实验室提供推进发现所需的试剂，支持了欧洲的科学研究。在我们的支持下，该公司将通过投资数字工具、加强供应商网络以及加速其并购平台来扩大其业务规模。”

We are proud to support a company that enables critical research and look forward to partnering with Europa Biosite's management team on the next leg of their journey.'.

我们很自豪能够支持一家进行关键研究的公司，并期待与欧罗巴生物公司的管理团队合作，共同踏上他们旅程的下一阶段。

'We're excited to partner with EQT for the next phase of growth. With growing demand for reagents and more scientists relying on these critical products, this is a pivotal moment for the business. EQT's expertise in scaling distributors will help us reach new customers, offer even better service, and bring exciting new products to market,' said Sune Schmølker, CEO of Europa Biosite..

“我们很高兴与EQT合作，共同进入下一个增长阶段。随着对试剂需求的不断增长以及越来越多科学家依赖这些关键产品，这对公司来说是一个关键时刻。EQT在扩展分销商方面的专业知识将帮助我们接触新客户、提供更优质的服务，并将令人兴奋的新产品推向市场，”Europa Biosite首席执行官Sune Schmølker表示。

Kate Swann

凯特·斯万

, Senior Industrial Advisor to EQT, commented: 'I am excited to be taking on the role of Chairperson of Europa Biosite and to continue the partnership with EQT. The life sciences sector is vital and fast-moving, and Europa Biosite has a compelling opportunity to grow and contribute to its development.

EQT的高级工业顾问评论道：“我很高兴能担任Europa Biosite的主席，并继续与EQT的合作。生命科学领域充满活力且发展迅速，Europa Biosite有极具吸引力的机会去成长并为其发展做出贡献。”

Building on my experience as Chairperson of Beijer Ref, another Swedish specialised distribution business, I look forward to supporting the company's scaling journey.'.

基于我担任另一家瑞典专业分销企业贝杰尔制冷公司董事长的经验，我期待着支持公司的规模化发展进程。

Contact

联系

EQT Press Office,

EQT新闻办公室，

press@eqtpartners.com

This information was brought to you by Cision

此信息由Cision提供

http://news.cision.com

https://news.cision.com/eqt/r/eqt-to-acquire-europa-biosite--a-distributor-of-life-science-products,c4185221

https://news.cision.com/eqt/r/eqt收购europa-biosite--生命科学产品分销商,c4185221

The following files are available for download: